Blood Purif 2017 3;44(3):244-250. Epub 2017 Oct 3.
Department of Nephrology, Hospital de Santa Cruz, Lisbon, Portugal.
Download full-text PDF
Int Urol Nephrol 2006 ;38(2):331-8
Nephrology Ward, Shariati Hospital, North Kargar Street, Postal code: 14114, Tehran, Iran.
Background: Controversy continues concerning the morbidity and mortality of HIV-infected ESRD patients on the two dialysis options. This article presents our experience with complications and survival rate among our HIV-infected ESRD patients on peritoneal dialysis and hemodialysis. We reviewed the literature on this subject. Read More
Clin Nephrol 1998 Dec;50(6):367-74
Department of Medicine, Bronx-Lebanon Hospital Center, Bronx, New York, USA.
Objective: End-stage renal disease (ESRD) patients infected with human immunodeficiency virus (HIV) have poor survival on maintenance hemodialysis. Only a few studies have evaluated survival time on the basis of demographic and clinical factors. The clinical category of the HIV infection and total CD4 counts are commonly considered determining factors of survival in these HIV-infected dialysis patients. Read More
J Acquir Immune Defic Syndr 2011 Aug;57(4):276-83
Hospital Sant Jaume de Olot University of Girona, Girona, Spain.
Background: Prognosis of HIV-infected patients on dialysis has improved. Few studies have compared survival between HIV-infected and HIV-negative patients on dialysis in the combined antiretroviral therapy (cART) era. We compared the outcome of HIV-infected patients on dialysis with a matched HIV-negative cohort. Read More
Clin Nephrol 1999 Jan;51(1):40-4
Department of Medicine, University of Texas Medical Branch at Galveston, 77555, USA.
Background: Plasma viral load has become an important test in predicting the progress of HIV-1 infected patients. The higher the viral load the faster is the progression to AIDS. As HIV-1 infected hemodialysis (HD) patients have higher mortality and morbidity than HIV-1 infected non-dialysis patients, and as all the blood tests in the HD patients are drawn during HD, we measured the effect of HD and antiretroviral therapy on viral load in HIV-1 infected HD patients. Read More